Project description
A comprehensive biomaterials database and tools aids both providers and users
Biomaterials are natural or man-made materials compatible with biological systems. Their use in medical applications is widespread and growing. Practitioners and user groups seeking information about biomaterials face challenges due to the lack of a well-structured and easily accessible advanced biomaterials database. The EU-funded BIOMATDB project is filling this gap. The team is creating a database supported by data analysis and visualisation tools to support the search and selection process. Furthermore, BIOMATDB will make it easier for companies to offer their products through a web-based information marketplace and digital advisors. Finally, the platform will include intelligent matching tools and decision support to ensure that supply finds demand.
Objective
Biomaterials in healthcare span almost all medical fields, ranging from recognised materials to high-innovative smart and multi-functional biomaterials. One of the main challenges is to provide accessible and well-structured data of biomaterials for all relevant practitioners and user groups.
BIOMATDB aims to create an advanced database for biomaterials providing detailed information on its properties. Flexible data analysis and visualisation tools support the search and selection process based on analyses of the results of biological testing of biomaterials from the scientific literature to incorporate data on as many of the material properties as possible.
BIOMATDB also provides a web-optimised information marketplace and digital advisors to support companies, especially SMEs, in offering their products and properly presenting themselves at global scale. Initiated by biomaterial use cases, the web application will match the suppliers and demanders through intelligent matching tools and step-by-step decision support.
BIOMATDB focuses on the creation of a label of biocompatibility to define the suitability of a biomaterial for use in a medical device or advanced therapy and to assist companies, especially SMEs, in choosing and facilitating market access for their products providing them a better guidance.
All created technical systems and data processing methods are tested within existing open innovation testbeds and validation groups. Intuitive training manuals and compact online video tutorials support the use of the database, marketplace and label. Appropriate business models are derived for securing the long-term sustainability of the created solutions.
The project has a significant impact on the findability and searchability of existing biomaterials at the pan-European level. It is an enabler for better uptake of biomaterials in future health applications and medical therapies.
Fields of science
Programme(s)
Funding Scheme
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinator
1060 Wien
Austria
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.